0 followers
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Stephen J. Russell
REVOLUTION Medicines
5 followers
Summit Therapeutics
5 followers
Dyne Therapeutics
3 followers
Gamida Cell
2 followers
Entrada Therapeutics
1 follower
Century Therapeutics
1 follower
Ardelyx
3 followers
Akoya Biosciences
2 followers
Biolinq
1 follower
Regulus Therapeutics
1 follower
Thermo Fisher Scientific
180 followers
Explore companies